Company Filing History:
2 out of 2 
1 out of 2,962 
Years Active: 2000-2002
Certainly! Here is the article about inventor Frederico J Gueiros-Filho:
Title: Innovator Spotlight: Frederico J Gueiros-Filho
Introduction:
Frederico J Gueiros-Filho, a renowned inventor based in Boston, MA, is at the forefront of medical device innovations with a focus on sustained delivery of therapeutically-significant substances. With a strong background in research and development, Gueiros-Filho has made significant contributions to the field of healthcare.
Latest Patents:
Gueiros-Filho's latest patents showcase his expertise in sustained delivery devices and methods. The first patent titled "Sustained delivery device and methods of making and using the same" introduces novel medical devices optimized for targeted and reversible delivery of immunostimulating agents and therapeutic substances such as enzymes, hormones, and neurotransmitters. The second patent highlights a sustained delivery device incorporating Leishmania protozoa, offering groundbreaking solutions for controlled substance delivery in medical treatments.
Career Highlights:
Throughout his career, Gueiros-Filho has been associated with innovative companies such as Symbiontics, Inc. and the Presidents and Fellows of Harvard University. His invaluable contributions have significantly impacted the development of cutting-edge medical technologies and treatment methodologies.
Collaborations:
Gueiros-Filho has had the privilege of collaborating with notable professionals in the industry, including Stephen M Beverley and Dennis E Vaccaro. These collaborations have led to the successful implementation of pioneering ideas and the advancement of medical science.
Conclusion:
In conclusion, Frederico J Gueiros-Filho's inventive spirit and dedication to revolutionizing healthcare have established him as a prominent figure in the field of medical device innovations. His latest patents exemplify his commitment to pushing the boundaries of sustained substance delivery, offering new possibilities for enhanced therapeutic outcomes. Gueiros-Filho's collaborations and career milestones underscore his profound impact on the industry and pave the way for future breakthroughs in medical technology.